Latest Breaking News On - Sean bohen - Page 2 : comparemela.com

Biotech Stocks, Pharma Heat Up In 2024 As Buyouts, Obesity And AI Drive Excitement

Biotech Stocks, Pharma Heat Up In 2024 As Buyouts, Obesity And AI Drive Excitement
investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.

United statesJohn evansSimeon georgeChristopher anzaloneVijay pandeLilly mounjaroBristol myersKyle rasbachSekar kathiresanTema etfsAndreessen horowitzRob etheringtonSean bohenEli lillyArnon rosenthalRaymond stevens

Biotech Stocks, Pharma Heat Up In 2024 As Buyouts, Obesity And AI Drive Excitement

United statesChristopher anzaloneKyle rasbachJohn evansAndreessen horowitzArnon rosenthalClene nanomedicineAlector rosenthalSimeon georgeRob etheringtonLilly mounjaroRaymond stevensEli lillySean bohenTema etfsVijay pande

Olema Pharmaceuticals, Inc (NASDAQ:OLMA) Sees Large Increase in Short Interest

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) was the recipient of a significant growth in short interest in the month of December. As of December 15th, there was short interest totalling 6,650,000 shares, a growth of 27.6% from the November 30th total of 5,210,000 shares. Based on an average daily volume of 777,800 shares, […]

United statesSean bohenCyrus harmonOlema pharmaceuticals price performanceJpmorgan chase coRoyal bankNews ratings for olema pharmaceuticals dailySecurities exchange commissionInstitutional investors weigh in on olema pharmaceuticalsEp wealth advisorsOlema pharmaceuticals incOlema pharmaceuticals company profileCitigroup incOlema pharmaceuticalsInsider activity at olema pharmaceuticalsGet free report

Analysts Set Olema Pharmaceuticals, Inc (NASDAQ:OLMA) PT at $21 20

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) has earned an average recommendation of “Buy” from the six research firms that are covering the company, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a buy recommendation. The average 12 month price objective among analysts that have covered the stock in the […]

G walmsley grahamSean bohenOlema pharmaceuticals tradingOlema pharmaceuticalsOlema pharmaceuticals company profileNews ratings for olema pharmaceuticals dailyDimensional fund advisorsPolar capital holdings plcOlema pharmaceuticals incBlackrock incAnalyst recommendations for olema pharmaceuticalsInstitutional investors weigh in on olema pharmaceuticalsJpmorgan chase coGet free reportMarketbeat ratingsFund advisors

Baystreet ca - How Recent Biotech Breakthroughs Are Changing the Fight Against Breast Cancer

USA News Group – More people are getting breast cancer this year. Around 300,000 women and 2,800 men will find out they have it. While 1 out of every 8 women will hear they have breast cancer sometime in their life, the good news is that more people .

United kingdomUnited statesAmanda pritchardThomas heinemanSean bohenAstrazeneca truqapMatt coffeyOncolytics biotech incOlema oncology incSociety for immunotherapy of cancerUnited states news groupArvinas incEuropean society for medical oncologyCancer researchPfizer incOncolytics biotech